UNIVERSAL HLTH SVCS INC's ticker is UHS and the CUSIP is 913903100. A total of 434 filers reported holding UNIVERSAL HLTH SVCS INC in Q4 2018. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
About UNIVERSAL HLTH SVCS INC
Universal Health Services Inc. (UHS) is a leading healthcare management company that operates acute care hospitals, behavioral health centers, and ambulatory centers across the United States, Puerto Rico, and the United Kingdom. The company has a strong reputation for providing high-quality healthcare services to patients and has been recognized for its commitment to patient care and safety.
UHS has a diverse portfolio of healthcare facilities that cater to a wide range of medical needs. The company's acute care hospitals provide a range of services, including emergency care, surgery, and diagnostic imaging. Its behavioral health centers offer inpatient and outpatient services for mental health and substance abuse disorders. The company's ambulatory centers provide a range of outpatient services, including primary care, specialty care, and diagnostic testing.
UHS has a strong leadership team that is committed to driving growth and innovation in the healthcare industry. The company's CEO, Alan B. Miller, has been with UHS since its inception in 1979 and has led the company through significant growth and expansion. Under his leadership, UHS has become one of the largest healthcare management companies in the world.
In conclusion, UHS is a leading healthcare management company that is committed to providing high-quality healthcare services to patients. With a diverse portfolio of healthcare facilities and a strong leadership team, UHS is well-positioned to continue driving growth and innovation in the healthcare industry.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $27,094,279 | -10.9% | 146,511 | -12.1% | 0.02% | -4.8% |
| Q1 2024 | $30,416,994 | +17.1% | 166,705 | -2.2% | 0.02% | +10.5% |
| Q4 2023 | $25,971,203 | +14.9% | 170,370 | -5.2% | 0.02% | 0.0% |
| Q3 2023 | $22,605,122 | -19.4% | 179,791 | +1.1% | 0.02% | -13.6% |
| Q2 2023 | $28,062,077 | +9.8% | 177,867 | -11.5% | 0.02% | +15.8% |
| Q1 2023 | $25,553,074 | -13.2% | 201,047 | -3.8% | 0.02% | -17.4% |
| Q4 2022 | $29,446,433 | +55.9% | 209,003 | -2.4% | 0.02% | +43.8% |
| Q3 2022 | $18,884,000 | -16.0% | 214,155 | -4.0% | 0.02% | -5.9% |
| Q2 2022 | $22,471,000 | -31.3% | 223,121 | -1.1% | 0.02% | -22.7% |
| Q1 2022 | $32,712,000 | +7.8% | 225,680 | -3.5% | 0.02% | +22.2% |
| Q4 2021 | $30,333,000 | -11.5% | 233,946 | -5.5% | 0.02% | -14.3% |
| Q3 2021 | $34,263,000 | -4.1% | 247,616 | +1.5% | 0.02% | 0.0% |
| Q2 2021 | $35,724,000 | +4.2% | 243,964 | -5.0% | 0.02% | 0.0% |
| Q1 2021 | $34,271,000 | -5.0% | 256,921 | -2.0% | 0.02% | -8.7% |
| Q4 2020 | $36,065,000 | -0.6% | 262,288 | -22.6% | 0.02% | -4.2% |
| Q3 2020 | $36,274,000 | +12.5% | 338,950 | -2.4% | 0.02% | +4.3% |
| Q2 2020 | $32,254,000 | -13.4% | 347,233 | -7.7% | 0.02% | -28.1% |
| Q1 2020 | $37,256,000 | -24.9% | 376,015 | +8.7% | 0.03% | -17.9% |
| Q4 2019 | $49,623,000 | -2.0% | 345,900 | +1.6% | 0.04% | -11.4% |
| Q3 2019 | $50,651,000 | +13.6% | 340,509 | -0.4% | 0.04% | +10.0% |
| Q2 2019 | $44,582,000 | -3.3% | 341,911 | -0.8% | 0.04% | -7.0% |
| Q1 2019 | $46,107,000 | +14.7% | 344,674 | -0.4% | 0.04% | 0.0% |
| Q4 2018 | $40,196,000 | +13.2% | 345,919 | +24.5% | 0.04% | +13.2% |
| Q3 2018 | $35,521,000 | +17.1% | 277,856 | +2.1% | 0.04% | +8.6% |
| Q2 2018 | $30,335,000 | +2.1% | 272,210 | +8.5% | 0.04% | -7.9% |
| Q1 2018 | $29,702,000 | +5.9% | 250,838 | +1.4% | 0.04% | +5.6% |
| Q4 2017 | $28,047,000 | +3.1% | 247,437 | +0.9% | 0.04% | -5.3% |
| Q3 2017 | $27,195,000 | -11.3% | 245,130 | -2.4% | 0.04% | -15.6% |
| Q2 2017 | $30,646,000 | +1.2% | 251,036 | +3.2% | 0.04% | -4.3% |
| Q1 2017 | $30,282,000 | +14.7% | 243,324 | -1.9% | 0.05% | +9.3% |
| Q4 2016 | $26,395,000 | -15.2% | 248,119 | -1.8% | 0.04% | -15.7% |
| Q3 2016 | $31,132,000 | -9.5% | 252,656 | -1.5% | 0.05% | -13.6% |
| Q2 2016 | $34,409,000 | +5.0% | 256,594 | -2.3% | 0.06% | +3.5% |
| Q1 2016 | $32,769,000 | +7.5% | 262,742 | +3.4% | 0.06% | +3.6% |
| Q4 2015 | $30,496,000 | -1.6% | 254,087 | +2.4% | 0.06% | -8.3% |
| Q3 2015 | $30,984,000 | -10.1% | 248,253 | +2.3% | 0.06% | -3.2% |
| Q2 2015 | $34,482,000 | +16.6% | 242,661 | -3.4% | 0.06% | +17.0% |
| Q1 2015 | $29,570,000 | +10.8% | 251,207 | +5.0% | 0.05% | +1.9% |
| Q4 2014 | $26,677,000 | +18.2% | 239,230 | +10.7% | 0.05% | +15.6% |
| Q3 2014 | $22,578,000 | +9.4% | 216,059 | +0.3% | 0.04% | +7.1% |
| Q2 2014 | $20,638,000 | +2.8% | 215,518 | -11.9% | 0.04% | 0.0% |
| Q1 2014 | $20,079,000 | +15.7% | 244,652 | +13.1% | 0.04% | +16.7% |
| Q4 2013 | $17,352,000 | – | 216,408 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solel Partners LP | 427,400 | $55,417,000 | 11.91% |
| Camber Capital Management LP | 1,650,000 | $213,939,000 | 7.35% |
| 140 Summer Partners LP | 306,454 | $39,735,000 | 6.17% |
| WESTPORT ASSET MANAGEMENT INC | 98,059 | $12,714,000 | 5.76% |
| NUANCE INVESTMENTS, LLC | 1,750,343 | $226,949,000 | 3.99% |
| Pavadi Capital LLC | 39,363 | $5,104,000 | 3.87% |
| Sivik Global Healthcare LLC | 60,000 | $7,780,000 | 3.33% |
| Glenview Capital Management | 776,618 | $100,696,000 | 2.15% |
| PFM Health Sciences, LP | 475,340 | $61,633,000 | 2.10% |
| HealthCor Management, L.P. | 285,620 | $37,033,000 | 2.02% |